Stockscreener 앱 받기
7.33
20.31%
-1.83
Zhengye Biotechnology Holding Ltd 주식(ZYBT)의 최신 뉴스
Zhengye Biotechnology Receives NASDAQ Delinquency Notice for Late Filing - TipRanks
Zhengye Biotechnology faces NASDAQ compliance issue By Investing.com - Investing.com Nigeria
Zhengye Biotechnology faces NASDAQ compliance issue - Investing.com
Zhengye Biotechnology Holding Limited Receives NASDAQ Delinquency Letter for Non-Compliance with Listing Requirements - Nasdaq
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewswire
The Alternative Data Center Stocks Nobody Is Watching Right Now - Energy & Capital
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Tesla, Regeneron Among Market Cap Stock Movers on Wednesday - Investing.com Australia
Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Tesla, UnitedHealth Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
Zhengye Biotechnology Delays 20-F Filing - TipRanks
Spotify, Regeneron lead Tuesday’s market cap stock movers By Investing.com - Investing.com South Africa
Timing the Bottom In Oil - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
The Only Nuclear Stocks to Buy Today - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital
Understanding ZYBT stock ratios for better investment decisions - uspostnews.com
Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com
Chinese Fire Up Their Most Powerful Nuclear Plant - Energy & Capital
If You’re Not Buying Oil Stocks Right Now, Then You Hate Money. - Energy & Capital
Catherine De Noire Reveals Uncomfortable Truth: Prostitutes Make Excellent Financial Advisors - Energy & Capital
Gold Is The Place To Be... Or Is It? - Energy & Capital
Buy Oil NOW, Thank Me Later - Energy & Capital
Warren Buffett Was Right Again, Here’s What He’s Doing Next - Energy & Capital
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st
Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance
Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks
Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Kroger CEO Questions Remain While the Market Moves on - Energy & Capital
This Silver Stock Is Like No Other - Energy & Capital
Trump’s Only Solution to Low Energy Prices - Energy & Capital
Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Data Gusher: The AI Arms Race Has Begun - Energy & Capital
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
Silver Depletion By 2050? What Will Happen To Tech? - Energy & Capital
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
The Best Nuclear Energy Stocks to Buy Now - Energy & Capital
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - renaissancecapital.com
The Secret Behind the Naughton Power Plant - Energy & Capital
Gold Mining Stocks ListUnearthing Opportunities in 2024 - Energy & Capital
Nvidia's Rise Points To Something Bigger - Energy & Capital
Electric Bike Stocks5 E-Bike Companies to Watch in 2024 - Energy & Capital
Why Does Elon's New Lithium Refinery Reek of the CCP? - Energy & Capital
New World Assets - Energy & Capital
Cotações de Ações Americanas (STOCKS) - Money Times
Markets Today — Quotes, Charts, and Events - TradingView
3.28%
2.99%
자본화:
|
볼륨(24시간):